Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Changzhou Qianhong Bio-Pharma Co., Ltd
WARNING LETTER
•Changzhou Qianhong Bio-Pharma Co., Ltd•July 9, 2013

Changzhou Qianhong Bio-Pharma Co., Ltd – FDA Warning Letter, Jul 9, 2013

Record Details

The FDA issued a Warning Letter to Changzhou Qianhong Bio-Pharma Co., Ltd on June 4, 2013, following a review of drug shipments into the U.S. and the company's drug registration and listing information. The review revealed the company failed to fulfill its registration obligations under the Federal Food, Drug, and Cosmetic Act (the Act).

Specifically, the company manufactured, prepared, propagated, compounded, or processed drugs imported or offered for import into the U.S. while not registered. This violates Section 510(i)(1) of the Act, which requires annual electronic registration for foreign establishments engaged in drug manufacturing for U.S. import. Failure to register is a prohibited act under Section 301(p) of the Act. Additionally, drugs from unregistered establishments may be refused admission under Section 801(a)(3) and are considered misbranded under Section 502(o) of the Act.

To remedy these violations, Changzhou Qianhong Bio-Pharma Co., Ltd must immediately register its establishment and properly list drugs offered for import. The company must notify the FDA in writing within fifteen working days of receipt of the letter, detailing corrective actions. If unable to complete actions within this timeframe, a reason for delay and a new completion date must be provided. If the company ceases U.S. drug imports, it must notify the FDA and provide discontinuance notice per Section

Company
Changzhou Qianhong Bio-Pharma Co., Ltd
Inspection date
July 9, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Douglas Stearn
View Company Profile

ID · 7431f83e-19a3-4c2e-bf37-9f76f4c1042b

Violation Codes6
21 U.S.C. 360(i)(1)21 U.S.C. 331(p)21 U.S.C. 381(a)(3)21 U.S.C. 352(o)21 U.S.C. 360(j)(2)21 CFR 207

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Changzhou Qianhong Bio-Pharma Co., Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.